NLRPs, microbiota, and gut homeostasis: unravelling the connection
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Within the NOD‐like receptor (NLR) family, there are several NLRP (NLR family, pyrin domain‐containing) proteins that are involved in the formation of inflammasomes. These multi‐protein complexes are a key part of the network of cellular events required for secretion of the pro‐inflammatory cytokines IL‐1β and IL‐18. The NLRP3 inflammasome is the best‐characterized member of the family and has recently been implicated in gut homeostasis and determining the severity of inflammation in inflammatory bowel disease (IBD) and inflammation‐associated colorectal cancer. This led to the discovery that NLRP6 and NLRP12 also contribute to the maintenance of intestinal homeostasis and modulation of the gut microbiota, which in turn influences the intestine and distant organs. In this review, we bring together the latest data on the potential roles of NLRP family members in gut health and disease and identify the most pressing questions that remain to be answered to further our understanding of human diseases including IBD, inflammation‐associated cancers, and metabolic syndromes linked with obesity. Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Non-canonical inflammasome activation targets caspase-11
Kayagaki, N., Warming, S., Lamkanfi, M., Walle, L. V., Louie, S., Dong, J., Newton, K., Qu, Y., Liu, J., Heldens, S., et al. (2011) · Nature · doi:10.1038/nature10558 · Cited by 2,530 · cited 4×
“This transferable phenotype appears to be mediated by an inflammasome, as both Asc−/− and Casp-1−/− mice showed the same increased colitis severity in response to DSS treatment.”
BackgroundInfluentialInflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435 · cited 3×
“J Pathol 2014; 233: 321–330 Published by John Wiley & Sons, Ltd. www.pathsoc.org.uk www.thejournalofpathology.com (NAFLD) [57] (for a review on this topic, see Bellentani et al [58]).”
BackgroundAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768 · cited 1×
“Even if the discovery of the inflammasome is relatively recent [14], studies on the role of the NLRP3 inflammasome downstream effectors IL-1β and IL-18 date back more than 20 years.”
BackgroundEpidemiology of Non-Alcoholic Fatty Liver Disease
Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010) · Digestive Diseases · doi:10.1159/000282080 · Cited by 1,026 · cited 2×
“J Pathol 2014; 233: 321–330 Published by John Wiley & Sons, Ltd. www.pathsoc.org.uk www.thejournalofpathology.com (NAFLD) [57] (for a review on this topic, see Bellentani et al [58]).”
BackgroundAllen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100050 · Cited by 826 · cited 4×
“Nlrp3−/− mice undergoing this protocol exhibited increased epithelial dysplasia and greater tumour burden in the colon compared with wild-type animals [24,39].”
BackgroundInfluentialWlodarska, M., Thaiss, C. A., Nowarski, R., Henao-Mejia, J., Zhang, J.-P., Brown, E. M., Frankel, G., Levy, M., Katz, M. N., Philbrick, W. M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.026 · Cited by 708
Self-Renewal and Cancer of the Gut: Two Sides of a Coin
Radtke, F., & Clevers, H. (2005) · Science · doi:10.1126/science.1104815 · Cited by 690
Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R.-M., Wang, E., Ma, W., Haines, D., O'hUigin, C., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100199 · Cited by 429 · cited 1×
“A similar increase in tumour burden was observed in the colons of AOM/DSS-treated Il18−/− and Il18r1−/− mice [39,42], further illustrating its importance during colitis-associated CRC development in this model.”
BackgroundZaki, M. H., Vogel, P., Body-Malapel, M., Lamkanfi, M., & Kanneganti, T.-D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002046 · Cited by 411 · cited 4×
“A similar increase in tumour burden was observed in the colons of AOM/DSS-treated Il18−/− and Il18r1−/− mice [39,42], further illustrating its importance during colitis-associated CRC development in this model.”
BackgroundInfluential
Cited by
Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
Gao, J., Xu, K., Liu, H., Liu, G., Bai, M., Peng, C., Li, T., & Yin, Y. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00013 · Cited by 1,298
Innate immunity in diabetes and diabetic nephropathy
Wada, J., & Makino, H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.175 · Cited by 427
NLRP3 inflammasome activation triggers gasdermin D–independent inflammation
Wang, C., Yang, T., Xiao, J., Xu, C., Alippe, Y., Sun, K., Kanneganti, T.-D., Monahan, J. B., Abu-Amer, Y., Lieberman, J., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj3859 · Cited by 307
Yue, C., Yang, X., Li, J., Chen, X., Zhao, X., Chen, Y., & Wen, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.075 · Cited by 120
Slyepchenko, A., Maes, M., Köhler, C. A., Anderson, G., Quevedo, J., Alves, G. S., Berk, M., Fernandes, B. S., & Carvalho, A. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.002 · Cited by 89
Inflammasomes and the microbiota–partners in the preservation of mucosal homeostasis
Levy, M., Thaiss, C. A., Katz, M. N., Suez, J., & Elinav, E. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0451-7 · Cited by 34
Metadata
- Authors
- Zambetti, L. P., & Mortellaro, A.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2014-05-16
- Volume
- 233
- Issue
- 4
- Pages
- 321-330
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2050614834
- Cited by
- 69
- References
- 9
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.